WallStreetZenWallStreetZen

NASDAQ: IGMS
Igm Biosciences Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

IGMS past revenue growth

How has IGMS's revenue growth performed historically?
Company
99.25%
Industry
144.63%
Market
17.55%
IGMS's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
IGMS's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
IGMS's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

IGMS earnings and revenue history

Current Revenue
$2.1M
Current Earnings
-$246.4M
Current Profit Margin
-11,568.8%

IGMS Return on Equity

Current Company
-103.2%
Current Industry
-63.5%
Current Market
188%
IGMS's Return on Equity (-103.2%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when IGMS announces earnings.

IGMS Return on Assets

Current Company
-53.5%
Current Industry
2.9%
IGMS is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

IGMS Return on Capital Employed

Current Company
-64.51%
Current Industry
19.5%
IGMS's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

IGMS vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
IGMS$2.13M-$232.05M-$246.42M+99.25%N/A
LYEL$130.00k-$214.38M-$234.63M-33.30%N/A
OLMA$0.00-$94.98M-$96.66MN/AN/A
GHRS$0.00-$34.55M-$35.59MN/AN/A
ORIC$0.00-$99.67M-$100.70MN/AN/A
View Top Biotech Stocks

IGMS earnings dates

Next earnings date
Jun 11, 2024

Igm Biosciences Earnings & Revenue FAQ

What were IGMS's earnings last quarter?

On Invalid Date, Igm Biosciences (NASDAQ: IGMS) reported Q4 2023 earnings per share (EPS) of -$0.98, up 16.24% year over year. Total Igm Biosciences earnings for the quarter were -$60.70 million. In the same quarter last year, Igm Biosciences's earnings per share (EPS) was -$1.17.

If you're new to stock investing, here's how to buy Igm Biosciences stock.

What was IGMS's earnings growth in the past year?

As of Q2 2024, Igm Biosciences's earnings has grown year over year. Igm Biosciences's earnings in the past year totalled -$246.42 million.

What is IGMS's earnings date?

Igm Biosciences's earnings date is Invalid Date. Add IGMS to your watchlist to be reminded of IGMS's next earnings announcement.

What was IGMS's revenue last quarter?

On Invalid Date, Igm Biosciences (NASDAQ: IGMS) reported Q4 2023 revenue of $651.00 thousand up 75% year over year. In the same quarter last year, Igm Biosciences's revenue was $372.00 thousand.

What was IGMS's revenue growth in the past year?

As of Q2 2024, Igm Biosciences's revenue has grown 99.25% year over year. This is 45.38 percentage points lower than the US Biotechnology industry revenue growth rate of 144.63%. Igm Biosciences's revenue in the past year totalled $2.13 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.